Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Microba Life Sciences's Enterprise Value is A$19.28 Mil.
Microba Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-19.86 Mil. Therefore, Microba Life Sciences's EV-to-EBIT ratio for today is -0.97.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Microba Life Sciences's Enterprise Value is A$19.28 Mil.
Microba Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-15.40 Mil. Therefore, Microba Life Sciences's EV-to-EBITDA ratio for today is -1.25.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Microba Life Sciences (ASX:MAP) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Microba Life Sciences's current Enterprise Value is A$19.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-19.86 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Microba Life Sciences's EV-to-EBITDA for today is:
Microba Life Sciences's current Enterprise Value is A$19.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-15.40 Mil.
Microba Life Sciences's current Enterprise Value is A$19.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$14.91 Mil.
Microba Life Sciences's current Enterprise Value is A$19.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-15.05 Mil.
Microba Life Sciences's current Enterprise Value is A$19.28 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Microba Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-18.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences Enterprise Value Related Terms
Microba Life Sciences Enterprise Value Historical Data
* Premium members only.
The historical data trend for Microba Life Sciences's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:MAP vs TMO, DHR, IDXX: Enterprise Value Comparison
For the Diagnostics & Research subindustry, Microba Life Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microba Life Sciences Enterprise Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Microba Life Sciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Microba Life Sciences's Enterprise Value falls into.
Microba Life Sciences Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Microba Life Sciences's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Microba Life Sciences (ASX:MAP) has a Enterprise Value of A$19.28 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Microba Life Sciences and its competitors.
Is Microba Life Sciences' Enterprise Value too high?
Microba Life Sciences' current Enterprise Value is A$19.28 Mil.
How does Microba Life Sciences' Enterprise Value compare to TMO and DHR?
Microba Life Sciences' Enterprise Value of A$19.28 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Diagnostics & Research company?
A good Enterprise Value depends on the Medical Diagnostics & Research industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Microba Life Sciences and its competitors. Microba Life Sciences's current Enterprise Value is A$19.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.25, compared to a current price of A$0.04 — trading 84% below its estimated fair value. The current Enterprise Value is A$19.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Enterprise Value is A$19.28 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MAP has been successfully added to your 